Navigation Links
Elevation Pharmaceuticals Completes $30 Million Series B Financing to Advance Aerosol COPD Therapy
Date:1/4/2012

SAN DIEGO, Jan. 4, 2012 /PRNewswire/ --  Elevation Pharmaceuticals, Inc. announced today the closing of a $30 million Series B financing, led by new investor Novo Ventures, to fund development of Elevation's new aerosol therapy for patients living with chronic obstructive pulmonary disease (COPD). All previous investors participated in the round, including Canaan Partners, TPG Biotech, Care Capital and Mesa Verde Venture Partners. In conjunction with this financing, Elevation has added Heath Lukatch, Ph.D., a Partner in Novo Ventures, Novo A/S, to its board of directors.

A currently-marketed long-acting muscarinic antagonist (LAMA) bronchodilator is the standard of care for treating moderate-to-severe COPD, but no LAMAs are approved for use in a nebulizer, which is the preferred delivery device for patients with more severe disease.  Elevation's lead product candidate, EP-101, is believed to be the only nebulized LAMA being developed for COPD. EP-101 is a proprietary inhalation solution formulation of glycopyrrolate that is being delivered by an investigational eFlow® Nebulizer System by PARI Pharma GmbH.

"We believe that Elevation Pharmaceuticals' EP-101 will provide a much needed new treatment option for an underserved segment of the COPD patient population. EP-101 has already demonstrated improved lung function in multiple human clinical trials and Elevation's management team has a successful track record of developing drugs using new delivery technologies. Novo Ventures is very pleased to be able to support Elevation's efforts to improve the lives of COPD patients with our investment in the company's Series B financing," said Dr. Lukatch.  

Elevation has completed enrollment of its multi-center Phase 2b clinic
'/>"/>

SOURCE Elevation Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Elevation Pharmaceuticals Strengthens Management Team with Appointment of Executives
2. Volcano Corporation Commends the Elevation of FFR to Level of Evidence A in New PCI Guidelines
3. Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline in Renal Function and Arterial Stiffness in Older Adults
4. Ranexa(R) Added to New ACC/AHA Guidelines on Unstable Angina/Non ST-Elevation Myocardial Infarction (UA/NSTEMI)
5. Auxilium Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
6. MAP Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
7. Jazz Pharmaceuticals to Hold Investor Conference Call on January 5 to Discuss 2012 Financial Guidance and Azur Pharma Transaction
8. Radient Pharmaceuticals Announces Reverse Stock Split
9. Idenix Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
10. Optimer Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
11. Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) (TSX: ... registered offering of common shares in the ... Offering, the Company issued 7,286,432 common shares at a ... of approximately $1.45 billion. On March 18, 2015, the ... a final prospectus supplement to its effective shelf registration ...
(Date:3/27/2015)... , March 27, 2015 As ... shipments of incontinence devices for women. ... the most gratifying part is the hundreds of ... women whose lives have been positively impacted by ... of InControl. InControl recently released Apex, ...
(Date:3/27/2015)... , March 27, 2015   Hospira, Inc. ... in biosimilars and the world,s leading provider of ... that support an evaluation of biosimilarity of its ... and Drug Administration (FDA) conditionally approved name of ... (epoetin alfa). These study data were presented at ...
Breaking Medicine Technology:Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 3InControl Medical Surpasses 40,000 Shipments Of Incontinence Devices For Women 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3
(Date:3/28/2015)... March 28, 2015 Emergency Medical Care ... care in Manhattan, recently commemorated its three-year anniversary of ... Manhattan. In addition to 24-hour urgent care, Emergency Medical ... , At this time, Emergency Medical Care’s Urgent ... asthma, chest pain, eye injuries, ear infections, fevers, insect ...
(Date:3/28/2015)... IL (PRWEB) March 28, 2015 Centurion Service ... equipment auction on Thursday, April 2 at their Las Vegas ... Vegas, NV 89081. The sale, which consists of equipment from ... begin promptly at 9 a.m. PDT. , Buyers will ... and surgery equipment. “We are a one-stop-shop,” said Erik Tivin, ...
(Date:3/28/2015)... Vegas, NV (PRWEB) March 28, 2015 ... injuries is a growing field in orthopaedic medicine. While ... labral tear to confirm the pain etiology, research presented ... ( AOSSM ) Specialty Day suggests that pain relief ... following arthroscopic hip surgery. , “Our study looked ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 Genomic medicine ... peritoneal mesothelioma, revealing, for the first time, key information ... here to read the newly posted story on ... the University of British Columbia, the British Columbia Cancer ... mapping to reveal underlying molecular alterations and mutations that ...
(Date:3/28/2015)... 28, 2015 Aureus Medical Group ... including physical therapy jobs, has announced that it ... Physical Therapy Association Annual Conference to be held ... Hotel in Columbus, OH. , The OPTA ... exhibits with products and services. , Representatives ...
Breaking Medicine News(10 mins):Health News:Emergency Medical Care Celebrates Three Years of 24/7 Walk-In Urgent Care Services 2Health News:Medical Equipment Auction to Take Place in North Las Vegas 2Health News:Pain Injections for Hip Arthroscopy Patients May Not Predict Surgical Outcomes 2Health News:New Genomics Research May Help Doctors Tailor Mesothelioma Treatment, According to Surviving Mesothelioma 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the Ohio Physical Therapy Association Annual Conference 2
... warning to expectant mothers to completely avoid consuming Vitamin E ... unborn child //. ,A leading obstetrician, Prof Stuart ... warning on Vitamin E following clinical trials that have revealed ... child. It is also known to increase the rates of ...
... to understand and prevent the spread of avian flu //. ... of Department for Food, Environment and Rural Affairs (Defra) Science ... contract and transmit the avian influenza virus has important human ... potential host for avian influenza because of the extensive infection ...
... metabolism, which occurs when the body has difficulty processing ... patients //with chronic nerve dysfunction of unknown cause than ... factor for the condition, according to a study posted ... print issue of Archives of Neurology, one of the ...
... CHICAGO - The number of mutations in a gene previously ... the age at which the condition develops; even individuals who ... Parkinson's disease, according to a report in the June issue ... , ,Parkinson's disease affects about 1 percent of individuals ...
... may be related to a reduced risk of developing ... in the June 12 //issue of Archives of Internal ... ,Cirrhosis progressively destroys healthy liver tissue and replaces it ... can cause cirrhosis, but long-term, heavy alcohol use is ...
... as transcendental meditation may decrease blood pressure and ... heart disease, according to a report in the ... one of the JAMA/Archives journals. , ... in India, is taught through a standard protocol ...
Cached Medicine News:Health News:Abnormal Glucose Metabolism May Contribute to Chronic Nerve Disorder 2Health News:Gene Mutation May Influence Age at Onset of Parkinson's Disease 2Health News:Coffee Drinking Associated with Lower Risk for Alcohol-Related Liver Disease 2Health News:Meditation may Improve Cardiac Risk Factors in Patients with Coronary Heart Disease 2
... Reichert MK1 Keratometer now utilizes ... consistent lighting, removing the need ... we didnt change are all ... made our Keratometer the worldwide ...
Agglutinating sera for serological identification of E. coli by slide and/or tube agglutination tests. Agglutinating sera are packaged 2 mL / vial....
... The innovative E.coli ... Pro-Lab offers definitive identification ... the use of a ... the possibility of cross-reactions ...
Inquire...
Medicine Products: